Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Background: Several measures have been developed to examine acute psychedelic effects (e.g. mystical-type and challenging experiences), but no measure assesses acute psychologically insightful experiences that may occur during psychedelic experiences. Aim: The purpose of this study was to develop and examine the psychometric properties of the Psychological Insight Questionnaire. Method: A cross-sectional survey study among psilocybin and LSD users. Respondents ( n=1661; M age =22.9, standard deviation=8.5; Caucasian/White=83%; non-Hispanic=91%; men=72%; United States resident=66%) completed an Internet-based survey. Results: The Psychological Insight Questionnaire consists of 23 items with two subscales: (a) Avoidance and Maladaptive Patterns Insights and (b) Goals and Adaptive Patterns Insights. Construct validity of the Psychological Insight Questionnaire was supported by strong correlations of the Psychological Insight Questionnaire (and Avoidance and Maladaptive Patterns Insights and Goals and Adaptive Patterns Insights subscales) scores with the insight subscale of the Session Impacts Scale, and weak-to-moderate correlations with the Mystical Experiences and Challenging Experiences Questionnaires. Furthermore, Psychological Insight Questionnaire (and Avoidance and Maladaptive Patterns Insights and Goals and Adaptive Patterns Insights subscales) scores were moderately-to-strongly correlated with retrospectively reported increases in psychological flexibility, and well-being/life satisfaction that were attributed to a memorable psychedelic experience. Lastly, incremental validity was established showing that the Psychological Insight Questionnaire (and Avoidance and Maladaptive Patterns Insights subscale) scores predict unique variance in changes in psychological flexibility, and Psychological Insight Questionnaire (and Avoidance and Maladaptive Patterns Insights and Goals and Adaptive Patterns Insights subscales) scores predict changes in well-being and life satisfaction, beyond measures of acute mystical-type and challenging effects. Conclusions: The Psychological Insight Questionnaire has the potential to extend the understanding of the acute and enduring effects of psychedelics. Further longitudinal research is necessary to determine the long-term predictive validity of the Psychological Insight Questionnaire and to examine the role of psychological insight in predicting therapeutic outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One example is the work of Davis et al. (2021) who, using a preliminary cross-sectional design, found relations between an original measure of insight (that appears theoretically comparable to cognitive reappraisal) and adaptive changes in psychological flexibility, well-being, and life satisfaction following use of a psychedelic.”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Davis et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“These results build upon previous cross-sectional work suggesting links between experiences of insight during a psychedelic and enhanced well-being and life satisfaction post-session (Davis et al., 2021).”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Davis et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“It has been found to have good psychometric properties (Davis et al., 2021).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Davis et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“It consists of 23 items and is rated on a six-point Likert scale, which loads onto the following two subscales: (a) Avoidance and Maladaptive Patterns Insights and (b) Goals and Adaptive Patterns Insights (Davis et al., 2021).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Davis et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“The Psychological Insight Questionnaire (PIQ) was developed by Davis et al. (2021) to measure new insights about one’s own personality, relationships, emotions, or behavioral patterns gained in the context of a discrete event (e.g., a psychedelic experience) (Davis et al., 2021).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Davis et al., 2021
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hu, L., & Bentler, P. M. (1999) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705519909540118 · Cited by 108,788 · cited 2×
“973) indicated acceptable model fit (Hu and Bentler, 1999).”
MethodInfluentialBond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950 · cited 1×
“The Acceptance and Action Questionnaire II (AAQII; Bond et al., 2011) was developed to measure psychological inflexibility.”
MethodThe satisfaction with life scale and the emerging construct of life satisfaction
Pavot, W., & Diener, E. (2008) · The Journal of Positive Psychology · doi:10.1080/17439760701756946 · Cited by 2,396 · cited 2×
“The Satisfaction with Life Scale (SWLS; Pavot and Diener, 2008) was used to examine the degree of changes in well-being and satisfaction with life that respondents experienced from before to after the identified psychedelic experience.”
MethodGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 2×
“…of laboratory and naturalistic studies of people with alcohol use problems, depression, and anxiety (Davis et al., 2020; Garcia-Romeu et al., 2019; Griffiths et al., 2016; Ross et al., 2016), and across a variety of psychedelic substances (Barsuglia et al., 2018; Bouso et al., 2016; Davis et al.,…”
BackgroundSelf-citationRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · cited 2×
“Furthermore, the MEQ has been shown to predict long-term positive therapeutic outcomes in a variety of laboratory and naturalistic studies of people with alcohol use problems, depression, and anxiety (Davis et al., 2020; Garcia-Romeu et al., 2019; Griffiths et al., 2016; Ross et al., 2016), and across a variety of psy…”
BackgroundGriffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Self-citationPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932 · cited 3×
“Email: davis.5996@osu.edu One of the most researched psychedelic effects is the “mystical” experience (Barrett et al., 2015; Griffiths et al., 2006, 2011).”
BackgroundSelf-citationGriffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905 · cited 3×
“, 2016), and across a variety of psychedelic substances (Barsuglia et al., 2018; Bouso et al., 2016; Davis et al., 2019; Griffiths et al., 2008; Liechti et al., 2017; Schmid and Liechti, 2018).”
BackgroundSelf-citationMacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895 · cited 2×
“Though much attention has been paid to the contribution of mystical-type experiences to positive outcomes of psychedelic experiences (Bogenschutz et al., 2015; Griffiths et al., 2006, 2008, 2011, 2016; MacLean et al., 2011), positive outcomes are possible in the absence of such effects (Roseman et al.”
BackgroundSelf-citationA new instrument for measuring insight: the Beck Cognitive Insight Scale
Beck, A. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00189-0 · Cited by 869 · cited 5×
“…been defined as the degree of clarity of understanding of one’s thoughts, feelings and behavior (Grant et al., 2002), awareness of internal states (Sutton, 2016), overconfidence in interpreting experiences (Beck et al., 2004), or capacity for introspection and self-examination (Conte et al., 1996).”
BackgroundMethodInfluentialRoseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808 · cited 12×
“Roseman et al. (2018) speculated that overcoming psychological resistance during a psilocybin experience may lead to emotional breakthrough and insight as measured by the “insightfulness” sub-factor.”
BackgroundResultInfluentialTHE SELF-REFLECTION AND INSIGHT SCALE: A NEW MEASURE OF PRIVATE SELF-CONSCIOUSNESS
Grant, A. M., Franklin, J., & Langford, P. (2002) · Social Behavior and Personality: an international journal · doi:10.2224/sbp.2002.30.8.821 · Cited by 772 · cited 5×
“It has also been defined as the degree of clarity of understanding of one’s thoughts, feelings and behavior (Grant et al., 2002), awareness of internal states (Sutton, 2016), overconfidence in interpreting experiences (Beck et al.”
BackgroundMethodInfluentialThe Construction and Preliminary Validation of a Measure of Reported Mystical Experience
Hood, R. W. (1975) · Journal for the Scientific Study of Religion · doi:10.2307/1384454 · Cited by 703
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683 · cited 9×
“…Questionnaire (Griffiths et al., 2006), Hallucinogen Rating Scale (Strassman et al., 1994), and Altered States of Consciousness Rating Scale (Studerus et al., 2010) were developed as standardized assessment tools to capture as many domains of the psychedelic experience as possible,…”
BackgroundMethodInfluentialValidation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115609019 · Cited by 637 · cited 8×
“The MEQ was used to assess the degree to which subjective mystical-type phenomena occurred during the reported psychedelic experience (Barrett et al., 2015; MacLean et al., 2012).”
BackgroundMethodResultSelf-citationWatts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · cited 1×
“Additionally, qualitative reports of acute psychedelic experiences have been published (Belser et al., 2017; Gasser et al., 2015; Watts et al., 2017), indicating that insight is a common feature of meaningful or therapeutic psychedelic experiences.”
BackgroundThe Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577 · cited 1×
“…Questionnaire (CEQ; Barrett et al., 2016) was created based on the Hallucinogen Rating Scale (HRS) (Strassman et al., 1994), the Altered States of Consciousness Rating Scale and the FiveDimensional Altered States of Consciousness Rating Scale (5DASC) (Dittrich, 1975, 1998; Studerus et al., 2010).”
MethodCarbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116662634 · Cited by 553 · cited 2×
“The CEQ was subsequently included in several studies of acute psychedelic effects, demonstrating that the CEQ can provide a standardized measure of acute challenging effects across different substances and settings (Barrett et al., 2016, 2017; Carbonaro et al., 2016; Davis et al., 2018, 2019; Haijen et al., 2018; Rose…”
BackgroundMethodSelf-citationGasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456 · cited 1×
“Additionally, qualitative reports of acute psychedelic experiences have been published (Belser et al., 2017; Gasser et al., 2015; Watts et al., 2017), indicating that insight is a common feature of meaningful or therapeutic psychedelic experiences.”
BackgroundStrassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · cited 6×
“…more precisely, the Challenging Experience Questionnaire (CEQ; Barrett et al., 2016) was created based on the Hallucinogen Rating Scale (HRS) (Strassman et al., 1994), the Altered States of Consciousness Rating Scale and the FiveDimensional Altered States of Consciousness Rating Scale…”
BackgroundMethodInfluentialPredicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417 · cited 2×
“The CEQ was subsequently included in several studies of acute psychedelic effects, demonstrating that the CEQ can provide a standardized measure of acute challenging effects across different substances and settings (Barrett et al., 2016, 2017; Carbonaro et al., 2016; Davis et al., 2018, 2019; Haijen et al., 2018; Rose…”
BackgroundMethodEmotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855974 · Cited by 413 · cited 7×
“The CEQ was subsequently included in several studies of acute psychedelic effects, demonstrating that the CEQ can provide a standardized measure of acute challenging effects across different substances and settings (Barrett et al., 2016, 2017; Carbonaro et al., 2016; Davis et al., 2018, 2019; Haijen et al., 2018; Rose…”
BackgroundMethodResultInfluentialMacLean, K. A., Leoutsakos, J. S., Johnson, M. W., & Griffiths, R. R. (2012) · Journal for the Scientific Study of Religion · doi:10.1111/j.1468-5906.2012.01685.x · Cited by 405 · cited 10×
“, 2015), and scores were moderately-to-strongly correlated with the Hood Mysticism Scale, demonstrating convergent validity (MacLean et al., 2012).”
BackgroundMethodResultSelf-citationDavis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.004 · Cited by 375 · cited 5×
“Several measures have been developed for assessment of acute subjective psychedelic drug effects that occur in the laboratory and in naturalistic settings (Davis et al., 2018, 2020; Griffiths et al., 2006, 2011; Kometer et al., 2015; Roseman et al., 2018; Russ et al., 2019).”
BackgroundResultSelf-citationBarrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116678781 · Cited by 366 · cited 9×
“Although mystical-type experiences are often occasioned by ingesting a psychedelic substance, challenging affective, physiological, and cognitive experiences also sometimes occurs (Barrett et al., 2016, 2017).”
BackgroundMethodSelf-citationGale, R. M. (1960) · The Journal of Philosophy · doi:10.2307/2023665 · Cited by 352
Belser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., Guss, J., Bossis, A., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817706884 · Cited by 311 · cited 1×
“Additionally, qualitative reports of acute psychedelic experiences have been published (Belser et al., 2017; Gasser et al., 2015; Watts et al., 2017), indicating that insight is a common feature of meaningful or therapeutic psychedelic experiences.”
BackgroundSelf-citationLong-lasting subjective effects of LSD in normal subjects.
Schmid, Y., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4733-3 · Cited by 232 · cited 2×
“, 2016), and across a variety of psychedelic substances (Barsuglia et al., 2018; Bouso et al., 2016; Davis et al., 2019; Griffiths et al., 2008; Liechti et al., 2017; Schmid and Liechti, 2018).”
BackgroundCessation and reduction in alcohol consumption and misuse after psychedelic use
Garcia-Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845793 · Cited by 225 · cited 8×
“, 2006; Pahnke, 1969) wherein participants were asked to rate the personal meaning, psychological challenge, psychological insight, and spiritual significance of their psychedelic experience (Garcia-Romeu et al., 2019).”
BackgroundResultSelf-citationAlterations of consciousness and mystical-type experiences after acute LSD in humans
Liechti, M. E., Dolder, P. C., & Schmid, Y. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4453-0 · Cited by 198 · cited 2×
“, 2016), and across a variety of psychedelic substances (Barsuglia et al., 2018; Bouso et al., 2016; Davis et al., 2019; Griffiths et al., 2008; Liechti et al., 2017; Schmid and Liechti, 2018).”
BackgroundMeasuring the effects of self-awareness: Construction of the Self-Awareness Outcomes Questionnaire
Sutton, A. (2016) · Europe’s Journal of Psychology · doi:10.5964/ejop.v12i4.1178 · Cited by 192 · cited 5×
“, 2014), Self-Awareness Outcomes Questionnaire (Sutton, 2016), Self-Reflection and Insight Scale (SRIS; Grant et al.”
BackgroundMethodInfluentialKometer, M., Pokorny, T., Seifritz, E., & Volleinweider, F. X. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4026-7 · Cited by 176 · cited 1×
“Several measures have been developed for assessment of acute subjective psychedelic drug effects that occur in the laboratory and in naturalistic settings (Davis et al., 2018, 2020; Griffiths et al., 2006, 2011; Kometer et al., 2015; Roseman et al., 2018; Russ et al., 2019).”
BackgroundElliott, R., & Wexler, M. M. (1994) · Journal of Counseling Psychology · doi:10.1037/0022-0167.41.2.166 · Cited by 157 · cited 10×
“Also supporting construct validity, a strong correlation was found between mean PIQ, and AMP and GAP subscale, scores and insight measured by mean SIS scores (PIQ: r=0.69, p<0.001; AMP: r=0.64, p<0.001; GAP: r=0.59, p<0.001).”
BackgroundMethodInfluentialDavis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1545024 · Cited by 142 · cited 5×
“, 2016), and across a variety of psychedelic substances (Barsuglia et al., 2018; Bouso et al., 2016; Davis et al., 2019; Griffiths et al., 2008; Liechti et al., 2017; Schmid and Liechti, 2018).”
BackgroundResultSelf-citationDavis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118769063 · Cited by 140 · cited 5×
“Several measures have been developed for assessment of acute subjective psychedelic drug effects that occur in the laboratory and in naturalistic settings (Davis et al., 2018, 2020; Griffiths et al., 2006, 2011; Kometer et al., 2015; Roseman et al., 2018; Russ et al., 2019).”
BackgroundResultSelf-citationPsychedelic drugs and mystical experience.
Pahnke, W. N. (1969) · PubMed · Cited by 138
The mediating role of insight for long-term improvements in psychodynamic therapy.
Johansson, P., Høglend, P., Ulberg, R., Amlo, S., Marble, A., Bøgwald, K.-P., Sørbye, Ø., Sjaastad, M. C., & Heyerdahl, O. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0019245 · Cited by 125 · cited 1×
“However, disparate operational definitions of insight limited such application of existing measures (Gibbons et al., 2007; Johansson et al., 2010; Lacewing, 2014; Moro et al., 2012; Sondhi et al., 2016).”
BackgroundNeuroticism is associated with challenging experiences with psilocybin mushrooms
Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2017) · Personality and Individual Differences · doi:10.1016/j.paid.2017.06.004 · Cited by 98 · cited 2×
“Although mystical-type experiences are often occasioned by ingesting a psychedelic substance, challenging affective, physiological, and cognitive experiences also sometimes occurs (Barrett et al., 2016, 2017).”
BackgroundSelf-citationFurther Factor Analysis of Hood's Mysticism Scale
Hood, R. W., Morris, R. J., & Watson, P. J. (1993) · Psychological Reports · doi:10.2466/pr0.1993.73.3f.1176 · Cited by 97
The psychological mindedness scale : factor structure and relationship to outcome of psychotherapy.
Conte, H. R., Ratto, R., & Karasu, T. B. (1996) · PubMed Central · Cited by 79
Barsuglia, J., Davis, A. K., Palmer, R., Lancelotta, R., Windham-Herman, A.-M., Peterson, K., Polanco, M., Grant, R., & Griffiths, R. R. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02459 · Cited by 79 · cited 2×
“, 2016), and across a variety of psychedelic substances (Barsuglia et al., 2018; Bouso et al., 2016; Davis et al., 2019; Griffiths et al., 2008; Liechti et al., 2017; Schmid and Liechti, 2018).”
BackgroundSelf-citationEvaluation of Results of Psychotherapy
ROSENBAUM, M., FRIEDLANDER, J., & KAPLAN, S. M. (1956) · Psychosomatic Medicine · doi:10.1097/00006842-195603000-00002 · Cited by 63 · cited 1×
“For example, the term insight has been used in psychiatric settings to convey a patient’s recognition of having an illness, understanding of contributing psychological factors, or belief that treatment could be helpful (Cleary et al., 2014; Rosenbaum et al., 1956).”
BackgroundInsight in Psychotherapy: A Review of Empirical Literature.
Gibbons, M. B. C., Crits-Christoph, P. F., Barber, J. P., & Schamberger, M. (2007) · American Psychological Association eBooks · doi:10.1037/11532-007 · Cited by 61 · cited 5×
“Apart from varying definitions of insight, much of the research in this area has to do with trait insightfulness rather than changes in insight secondary to treatment (i.e. acute insight experiences in the context of a discrete event) (Gibbons et al., 2007).”
BackgroundInfluentialStates and traits related to the quality and consequences of psychedelic experiences.
Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. (2019) · Psychology of Consciousness: Theory, Research, and Practice · doi:10.1037/cns0000169 · Cited by 55 · cited 2×
“Several measures have been developed for assessment of acute subjective psychedelic drug effects that occur in the laboratory and in naturalistic settings (Davis et al., 2018, 2020; Griffiths et al., 2006, 2011; Kometer et al., 2015; Roseman et al., 2018; Russ et al., 2019).”
BackgroundBouso, J. C., Pedrero-Pérez, E. J., Gandy, S., & Alcázar-Córcoles, M. Á. (2016) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2545 · Cited by 48 · cited 2×
“, 2016), and across a variety of psychedelic substances (Barsuglia et al., 2018; Bouso et al., 2016; Davis et al., 2019; Griffiths et al., 2008; Liechti et al., 2017; Schmid and Liechti, 2018).”
BackgroundPROGRESSIVE CHANGES IN PATIENTS' LIVES AFTER PSYCHOTHERAPY: WHICH TREATMENT EFFECTS SUPPORT THEM?
Grande, T., Rudolf, G., Oberbracht, C., & Pauli-Magnus, C. (2003) · Psychotherapy Research · doi:10.1093/ptr/kpg006 · Cited by 40 · cited 1×
“Similarly, Grande et al. (2003) found that patients with psychosomatic, “neurotic,” and personality disorders who gained insight over the course of psychotherapy, as measured by a clinician rater, had improved ability to cope by the end of treatment.”
BackgroundInsight and symptom reduction in time-limited psychoanalytic counseling.
Kivlighan, D. M., Multon, K. D., & Patton, M. J. (2000) · Journal of Counseling Psychology · doi:10.1037/0022-0167.47.1.50 · Cited by 38 · cited 2×
“For example, Kivlighan et al. (2000) found that self-reported insight, as defined by conscious awareness of thoughts and feelings contributing to distress, increased over the course of 20 psychoanalytic psychotherapy sessions.”
BackgroundMethodCleary, S. D., Bhatty, S., Broussard, B., Cristofaro, S. L., Wan, C. R., & Compton, M. T. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.01.043 · Cited by 28 · cited 4×
“Accordingly, several measures with disparate underlying operational definitions of insight have been developed, including the Birchwood Insight Scale for Psychosis (Cleary et al., 2014), Self-Awareness Outcomes Questionnaire (Sutton, 2016), Self-Reflection and Insight Scale (SRIS; Grant et al., 2002), Beck Cognitive I…”
BackgroundInfluentialChanges in the patient's level of insight in brief psychotherapy: Two pilot studies.
O’Connor, L. E., Edelstein, S. B., Berry, J. W., & Weiss, J. (1994) · Psychotherapy · doi:10.1037/0033-3204.31.3.533 · Cited by 27 · cited 1×
“This point was further demonstrated by O’Connor et al. (1994) who found that insight followed a “high-lowhigh” pattern over a 16-week course of psychotherapy.”
BackgroundPsychodynamic psychotherapy, insight, and therapeutic action
Lacewing, M. (2014) · Clinical Psychology: Science and Practice · doi:10.1111/cpsp.12065 · Cited by 27 · cited 1×
“However, disparate operational definitions of insight limited such application of existing measures (Gibbons et al., 2007; Johansson et al., 2010; Lacewing, 2014; Moro et al., 2012; Sondhi et al., 2016).”
BackgroundMallinckrodt, B. S. (1994) · Journal of Counseling Psychology · doi:10.1037//0022-0167.41.2.186 · Cited by 14 · cited 2×
“As Mallinckrodt (1994) suggested, insight may be an evolving process.”
BackgroundMallinckrodt, B. S. (1994) · Journal of Counseling Psychology · doi:10.1037/0022-0167.41.2.186 · Cited by 10
Moro, L., Avdibegović, E., & Moro, I. N. (2012) · PubMed · Cited by 3
Insight: A Confounding Variable in Therapy for Patients with Mood Disorders
Sondhi, R., Chhibber, K., & Parikh, S. (2016) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000250 · Cited by 3 · cited 1×
“However, disparate operational definitions of insight limited such application of existing measures (Gibbons et al., 2007; Johansson et al., 2010; Lacewing, 2014; Moro et al., 2012; Sondhi et al., 2016).”
Background
Research works printed but not linked: 7
- Barrett FS, 2015, Psychopharmacology, 29
- Conte HR, 1996, J Psychother Pract Res, 5, 250
- Dittrich A, 1975, Z Klin Psychol Psychiatr Psychother, 23, 12
- Doblin R, 1991, J Transpers Psychol, 23, 1
- Moro L, 2012, Psychiatr Danub, 24, 354
- Pahnke WN, 1969, Int Psychiatry Clin, 5, 149
- R Core Team, 2012, A Language and Environment for Statistical Computing
Cited by
Peill, J. M., Trinci, K. E., Kettner, H., Mertens, L. J., Roseman, L., Timmermann, C., Rosas, F. E., Lyons, T., & Carhart-Harris, R. L. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211066709 · Cited by 141
“Furthermore, acute insightfulness in association with a psychedelic experience was found to promote psychological flexibility and subsequent mental health improvements in individuals reporting histories of depression and anxiety (Davis et al., 2020a, 2020b, 2021b).”
BackgroundMethodInfluentialAgin-Liebes, G., Haas, T. F., Lancelotta, R., Uthaug, M. V., Ramaekers, J. G., & Davis, A. K. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00018 · Cited by 124
Self-citationKangaslampi, S. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00243 · Cited by 124
“These included surveys among 320 French-speaking, 288 Finnish-speaking, and 1,661 English-speaking users of any psychedelic (Davis et al., 2021; Fauvel, Kangaslampi, Strika-Bruneau, Roméo, & Piolino, 2022; Kangaslampi, Hausen, & Rauteenmaa, 2020) and among 6,877 ayahuasca users from several…”
InfluentialWilliams, M. T., Davis, A. K., Xin, Y., Sepeda, N. D., Grigas, P. C., Sinnott, S., & Haeny, A. M. (2021) · Drugs: Education, Prevention and Policy · doi:10.1080/09687637.2020.1854688 · Cited by 101
Self-citationLevin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., Barrett, F. S., Griffiths, R. R., & Davis, A. K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300501 · Cited by 82
Self-citation
Metadata
- Authors
- Davis, A. K., Barrett, F. S., So, S., Gukasyan, N., Swift, T. C., & Griffiths, R. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Davis, Alan K
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2021-01-09
- Volume
- 35
- Issue
- 4
- Pages
- 437-446
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC8056708
- OpenAlex
- W3118498264
- Semantic Scholar
- 43b50d44ebb4497a0d5ff95b145bbb98e85e52d9
- Cited by
- 169
- References
- 54
- Citations by year
- 2026: 20 · 2025: 30 · 2024: 48 · 2023: 44 · 2022: 16 · 2021: 10
- FWCI
- 20.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01DA003889, R01DA038890, T32DA007209)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psychedelic experience, psilocybin, LSD, psychological insight, psychological flexibility, well-being, life satisfaction, mystical experience, challenging experiences, scale development, psychometric properties, incremental validity
- MeSH terms
- Adaptation, Psychological, Adult, Avoidance Learning, Cross-Sectional Studies, Female, Hallucinogens, Humans, Lysergic Acid Diethylamide, Male, Mysticism, Psilocybin, Psychometrics, Surveys and Questionnaires, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.